A recent study led by Weill Cornell Medicine researchers demonstrates that artificial intelligence (AI) can enhance the identification of patients with advanced heart failure using cardiac ultrasound data. Traditionally diagnosed through cardiopulmonary exercise testing (CPET) in specialized centers, many of the estimated 200,000 individuals in the U.S. with this condition are overlooked due to accessibility issues. The new AI method accurately predicts peak oxygen consumption (peak VO2) using easily obtainable ultrasound images alongside electronic health records. This innovation promises a more efficient assessment process, potentially improving care for those with advanced heart failure. The study is part of the Cardiovascular AI Initiative involving Cornell and Columbia universities, focusing on AI’s application in improving heart failure diagnosis and management. Results indicate an accuracy rate of approximately 85% in distinguishing high-risk patients, paving the way for clinical trials and FDA approval that could revolutionize patient outcomes and quality of life.
Source link
Share
Read more